Advertisement

Topics

LabCorp to buy Chiltern for approximately $1.2bn

19:00 EDT 31 Jul 2017 | Pharmaceutical Technology

US-based global life sciences company LabCorp is set to acquire Chiltern, a specialist contract research organisation (CRO), in an all-cash transaction valued at approximately $1.2bn.

Original Article: LabCorp to buy Chiltern for approximately $1.2bn

NEXT ARTICLE

More From BioPortfolio on "LabCorp to buy Chiltern for approximately $1.2bn"

Quick Search
Advertisement
 

Relevant Topic

Clinical Research Organization
Contract Research Organization (CRO) provide research services outsourced on a contract basis to the pharmaceutical, biotechnology, healthcare and medical device industries: biopharmaceutical development biologic assay development commercial...